trial

Transcranial Direct Current Stimulation and Effects on Early Auditory Processing in Schizophrenia

NCTId NCT03537703
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 35 (actual)
Sponsored by VA Greater Los Angeles Healthcare System
Primary completion 2020-05-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
35 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2018-05-20
Primary completion
2020-05-01
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Active tDCS + Auditory Training

Sponsors

VA Greater Los Angeles Healthcare SystemLead Sponsor

Investigators

1
Walter DunnPrincipal Investigator

Sites

1 total
Los Angeles, United States

Facts & assertions

4 sourced
Enrollment
35
Phase
NA
Primary Completion Date
2020-05-01
Status
COMPLETED
relationships
The graph out of here
drug
Active tDCS + Auditory Training
drug
lead_sponsor
VA Greater Los Angeles Healthcare System
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Walter Dunn
person